Correlation Between Seres Therapeutics and INC Research

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and INC Research at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and INC Research into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and INC Research Holdings, you can compare the effects of market volatilities on Seres Therapeutics and INC Research and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of INC Research. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and INC Research.

Diversification Opportunities for Seres Therapeutics and INC Research

0.56
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Seres and INC is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and INC Research Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INC Research Holdings and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with INC Research. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INC Research Holdings has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and INC Research go up and down completely randomly.

Pair Corralation between Seres Therapeutics and INC Research

Given the investment horizon of 90 days Seres Therapeutics is expected to generate 1.47 times more return on investment than INC Research. However, Seres Therapeutics is 1.47 times more volatile than INC Research Holdings. It trades about 0.05 of its potential returns per unit of risk. INC Research Holdings is currently generating about -0.14 per unit of risk. If you would invest  81.00  in Seres Therapeutics on August 28, 2024 and sell it today you would earn a total of  8.00  from holding Seres Therapeutics or generate 9.88% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Seres Therapeutics  vs.  INC Research Holdings

 Performance 
       Timeline  
Seres Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Seres Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Seres Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.
INC Research Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days INC Research Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Seres Therapeutics and INC Research Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Seres Therapeutics and INC Research

The main advantage of trading using opposite Seres Therapeutics and INC Research positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, INC Research can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INC Research will offset losses from the drop in INC Research's long position.
The idea behind Seres Therapeutics and INC Research Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing